Imaging3, Inc. Hosts Annual Shareholder Meeting

BURBANK, CA--(Marketwire - January 25, 2011) -

Imaging3™, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, hosted their annual shareholder meeting on January 20, 2011 at its corporate offices located at 3200 West Valhalla Drive, Burbank, California 91505.

A quorum of outstanding voting shares of the Company was present at the meeting in person or by proxy. Shareholders were asked to consider and vote on five proposals which amended the Company’s Articles of Incorporation.

Proposal One increased the number of Authorized common stock to 750,000,000 shares and was approved by 86% of the voting shares.

Proposal Two voted to Authorize 1,000,000 shares of preferred stock and was approved by 79% of the votes cast.

Proposal Three increased the size of the Company’s Board of Directors from two (2) to a range of five (5) to nine (9) with an exact number of directors to be seven (7). The measure was approved by 96% of the voting shares.

Proposal Four provided for the election of three members of the Board of Directors to hold office until the next annual meeting of Shareholders or until their respective successors have been elected and qualified. The proposal was approved by 93% of the votes cast.

Proposal Five ratified the appointment of the Company’s independent registered public accounting firm, M&K CPAS, PLLC, until the end of the fiscal year ending December 31, 2010 and was approved by 85% of the voting shares.

Mr. Dean Janes, Chairman and CEO, presented a general overview of the Company’s business and after votes were cast and tabulated, answered Shareholder questions until the meeting was adjourned.

About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company’s website at http://www.imaging3.com for more information

Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company.